14th Floor Records

LEADING EDGE MATERIALS ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD THURSDAY, APRIL 25, 2024

Retrieved on: 
Wednesday, March 27, 2024
Remuneration, Computershare, 14th Floor Records, Notice, Corporation, Euroclear, CDS, FRA, Bank statement

The record date for the Meeting is March 19, 2024.

Key Points: 
  • The record date for the Meeting is March 19, 2024.
  • The Notice of Meeting, the accompanying Management Proxy Circular and related meeting materials are available under the Company’s profile on SEDAR at www.sedar.com and on the Company’s website at https://leadingedgematerials.com/ .
  • The information in this section is of significance to Shareholders who hold their securities (“Euroclear Registered Securities“) through Euroclear Sweden AB, which securities trade on the Nasdaq First North.
  • Shareholders who hold Euroclear Registered Securities are not registered holders of voting securities for the purposes of voting at the Meeting.

LEADING EDGE MATERIALS ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD WEDNESDAY, APRIL 26, 2023

Retrieved on: 
Thursday, March 30, 2023
Euroclear, Nasdaq First North, Bank statement, FRA, CDS, Corporation, Notice, 14th Floor Records, SEDAR, Computershare, Remuneration, Management, Audit, Holding company, Security (finance), Meeting

The record date for the Meeting is March 22, 2023.

Key Points: 
  • The record date for the Meeting is March 22, 2023.
  • The Notice of Meeting, the accompanying Management Proxy Circular and related meeting materials are available under the Company’s profile on SEDAR at www.sedar.com and on the Company’s website at https://leadingedgematerials.com/ .
  • The information in this section is of significance to Shareholders who hold their securities (“Euroclear Registered Securities“) through Euroclear Sweden AB, which securities trade on the Nasdaq First North.
  • Shareholders who hold Euroclear Registered Securities are not registered holders of voting securities for the purposes of voting at the Meeting.

Nederlander Theatrical Corp. Provides Notice of Data Security Event

Retrieved on: 
Saturday, December 10, 2022
Nature, Name, Social Security, 1501 Broadway, Privacy, Social, Nederlander, 14th Floor Records, Risk, Holiday, Environment, Online shopping, Risk management, Experian

NEW YORK, Dec. 9, 2022 /PRNewswire/ -- Nederlander became aware of suspicious activity in its environment. We immediately took steps to secure our network, and launched an investigation with the assistance of third-party experts to determine the nature and scope of the incident. Through the investigation, we determined that Nederlander was the target of a cyber-attack that impacted our network and that certain files were subject to unauthorized access. As such, we reviewed the contents of those files to determine what information was contained therein and to whom it related.  Upon completion of this review on October 21, 2022, we then worked diligently through November 14, 2022 to reconcile this information with our internal records to confirm the individuals whose information may have been affected and the appropriate contact information for those individuals to the extent possible. 

Key Points: 
  • Through the investigation, we determined that Nederlander was the target of a cyber-attack that impacted our network and that certain files were subject to unauthorized access.
  • As part of our ongoing commitment to the privacy and security of personal information in our care, we are reviewing our existing policies and procedures relating to data protection and security.
  • We are also providing notice of this event to state regulators, where required.
  • Additional information regarding this event and steps individuals may take may be found at www.nederlander.com ,

Capital Southwest Corporation Closes Public Offering of Common Stock

Retrieved on: 
Thursday, November 17, 2022
COVID-19, Growth, UBS, Attention, Telephone, LIBOR, Capital, Oppenheimer, Prospectus, Goldman Sachs, Wells Fargo, Security (finance), 14th Floor Records, Sale, Form, Investment, Acquisition, Life insurance, Financial adviser

DALLAS, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (NASDAQ: CSWC) (the Company or Capital Southwest) announced that it has closed an underwritten public offering of 2,534,436 shares of its common stock at a public offering price of $18.15 per share.

Key Points: 
  • DALLAS, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (NASDAQ: CSWC) (the Company or Capital Southwest) announced that it has closed an underwritten public offering of 2,534,436 shares of its common stock at a public offering price of $18.15 per share.
  • The total amount of shares issued includes the underwriters full exercise of their option to purchase an additional 330,579 shares of the Companys common stock.
  • The Company received approximately $44.0 million in net proceeds from this offering, after deducting underwriting discounts and estimated offering expenses.
  • This press release may contain certain forward-looking statements within the meaning of the federal securities laws, including statements with regard to Capital Southwests offering of its common stock, the expected net proceeds from the offering, and the anticipated use of the net proceeds of the offering.

Capital Southwest Corporation Prices Public Offering of Common Stock

Retrieved on: 
Tuesday, November 15, 2022
COVID-19, Growth, UBS, Attention, Telephone, LIBOR, Capital, Oppenheimer, Prospectus, Goldman Sachs, Wells Fargo, Security (finance), 14th Floor Records, Sale, Form, Investment, Acquisition, Life insurance, Financial adviser

DALLAS, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (NASDAQ: CSWC) (the Company or Capital Southwest) announced that it has priced an underwritten public offering of 2,203,857 shares of its common stock at a public offering price of $18.15 per share.

Key Points: 
  • DALLAS, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (NASDAQ: CSWC) (the Company or Capital Southwest) announced that it has priced an underwritten public offering of 2,203,857 shares of its common stock at a public offering price of $18.15 per share.
  • Capital Southwest has also granted the underwriters a 30-day option to purchase up to 330,579 additional shares of its common stock.
  • Net proceeds from the offering, after deducting underwriting discounts and estimated offering expenses payable by the Company, are expected to be approximately $38.2 million.
  • This press release may contain certain forward-looking statements within the meaning of the federal securities laws, including statements with regard to Capital Southwests offering of its common stock, the expected net proceeds from the offering, and the anticipated use of the net proceeds of the offering.

Capital Southwest Corporation Announces Offering of Shares of Common Stock

Retrieved on: 
Monday, November 14, 2022
COVID-19, Growth, UBS, Attention, Telephone, LIBOR, Capital, Prospectus, Goldman Sachs, Wells Fargo, Security (finance), 14th Floor Records, Sale, Form, Investment, Acquisition, Bank, Financial adviser

DALLAS, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (NASDAQ: CSWC) (the Company or Capital Southwest) today announced that it has commenced an underwritten public offering of shares of its common stock of approximately $46.0 million.

Key Points: 
  • DALLAS, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (NASDAQ: CSWC) (the Company or Capital Southwest) today announced that it has commenced an underwritten public offering of shares of its common stock of approximately $46.0 million.
  • In connection with the proposed offering, the Company intends to grant the underwriters a 30-day option to purchase additional shares of its common stock.
  • All of the shares of common stock to be sold in the offering are to be sold by the Company.
  • The offering is subject to general market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the size or terms of the offering.

Kaplan Fox & Kilsheimer LLP Announce A Proposed Class Action Settlement for All Persons and Entities Who Purchased or Otherwise Acquired Textron Inc. Common Stock Between January 31, 2018 and December 6, 2018, Inclusive

Retrieved on: 
Monday, September 26, 2022
Settlement, 14th Floor Records, Claim, Post office box, NYSE, Class Action, THE, Clerk, DO, United States district court, Green County Court Clerk's Office, Federal Rules of Civil Procedure, Hearing, Person, AND, United States Senate Judiciary Subcommittee on Federal Courts, Oversight, Agency Action and Federal Rights, Leading Counsel, Court, Motion, Telephone, Agreement, THIS, District court, Notice, ALL, Third Avenue, Pearl Street, COMMON, Online gambling, Insurance, Action

EXCHANGES OR IN A U.S. TRANSACTION BETWEEN JANUARY 31, 2018 AND DECEMBER 6, 2018, INCLUSIVE (THE "SETTLEMENT CLASS").

Key Points: 
  • EXCHANGES OR IN A U.S. TRANSACTION BETWEEN JANUARY 31, 2018 AND DECEMBER 6, 2018, INCLUSIVE (THE "SETTLEMENT CLASS").
  • Certain persons and entities are excluded from the Settlement Class as set forth in the Stipulation and Agreement of Settlement dated June 23, 2022 ("Stipulation") and the Notice described below.
  • IF YOU ARE A MEMBER OF THE SETTLEMENT CLASS, YOUR RIGHTS WILL BE AFFECTED BY THE SETTLEMENT OF THIS ACTION, AND YOU MAY BE ENTITLED TO SHARE IN THE SETTLEMENT FUND.
  • Note that the Court can only approve or deny the Settlement, not change the terms of the Settlement.

Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point Therapeutics

Retrieved on: 
Tuesday, August 16, 2022
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, BY, Multimedia, Securities Act of 1933, Bristol Myers Squibb, Risk, HSR, BMY, Forward-looking statement, NYSE, Schedule, Federal Cartel Office, AS, YouTube, SEC, Securities Exchange Act of 1934, Sumathi Best Television Current Reporting Award, TRK, Annual report, Communication, Patient, Instagram, Therapy, FCO, Large-cell lung carcinoma, Letter, Hart–Scott–Rodino Antitrust Improvements Act, Twitter, ROS1, AND, Corporation, Acquisition, TIME, Turning Point, NASDAQ, 14th Floor Records, LinkedIn, Pharmaceutical industry, Security (finance), Facebook

The expiration of the HSR Act waiting period occurred at 11:59 p.m. Eastern Time on August 15, 2022, and the FCO clearance was received on August 15, 2022.

Key Points: 
  • The expiration of the HSR Act waiting period occurred at 11:59 p.m. Eastern Time on August 15, 2022, and the FCO clearance was received on August 15, 2022.
  • Turning Point shareholders can direct questions regarding the Offer to MacKenzie Partners, Inc., the information agent for the Offer, toll free, at 1-800-322-2885.
  • For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn , Twitter , YouTube , Facebook , and Instagram .
  • Neither Bristol Myers Squibb nor Turning Point undertakes any obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

Bristol Myers Squibb Announces Extension of Turning Point Tender Offer

Retrieved on: 
Tuesday, July 19, 2022
Biotechnology, Pharmaceutical, Health, SEC, Right to Make Transmittable, BMY, Acquisition, U.S. Securities and Exchange Commission, Letter, Bristol Myers Squibb, EACH, Patient, LinkedIn, Agreement, Communication, TIME, BY, Tender, Securities Exchange Act of 1934, Forward-looking statement, NYSE, Schedule, Twitter, 14th Floor Records, Eastern Time Zone, Turning Point, Securities Act of 1933, Plan, NASDAQ, Sumathi Best Television Current Reporting Award, Instagram, Risk, Tax, Annual report, YouTube, AND, Corporation, Common stock, Cryptocurrency, Pharmaceutical industry, Facebook

This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell securities, nor is it a substitute for the tender offer materials that Bristol Myers Squibb and Offeror filed with the SEC.

Key Points: 
  • This communication is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell securities, nor is it a substitute for the tender offer materials that Bristol Myers Squibb and Offeror filed with the SEC.
  • At the time the tender offer was commenced, Bristol Myers Squibb caused Offeror to file a tender offer statement on Schedule TO and Turning Point filed a recommendation statement on Schedule 14D-9.
  • You may read any reports, statements or other information filed by Bristol Myers Squibb or Turning Point with the SEC at no charge on the SECs website at www.sec.gov .
  • Neither Bristol Myers Squibb nor Turning Point undertakes any obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

KKR Real Estate Finance Trust Inc. Announces Pricing of Public Offering of Common Stock

Retrieved on: 
Friday, June 3, 2022
Commercial Building & Real Estate, Construction & Property, Professional Services, Finance, Exercise, Goldman Sachs, Form S-3, Offering, Varick Street, Deutsche Bank, Form, J. P. Morgan, 2nd Floor (Nina song), Forward-looking statement, KKR, Security (finance), Barclays, Bangladesh Securities and Exchange Commission, Hudson Yards, KREF, Wells Fargo, Sale, Citigroup, Keefe, Bruyette & Woods, Private Securities Litigation Reform Act, 14th Floor Records, Prospectus, NYSE, Risk, SEC, Morgan Stanley, Attention, Property management

KKR Real Estate Finance Trust Inc. (KREF) (NYSE: KREF) today announced the pricing of a public offering of 7,000,000 shares of KREF common stock (the Offering), consisting of 2,750,000 primary shares to be issued and sold by KREF and 4,250,000 secondary shares to be sold by KKR REFT Holdings L.P., a subsidiary of KKR & Co. Inc. (the KKR Stockholder).

Key Points: 
  • KKR Real Estate Finance Trust Inc. (KREF) (NYSE: KREF) today announced the pricing of a public offering of 7,000,000 shares of KREF common stock (the Offering), consisting of 2,750,000 primary shares to be issued and sold by KREF and 4,250,000 secondary shares to be sold by KKR REFT Holdings L.P., a subsidiary of KKR & Co. Inc. (the KKR Stockholder).
  • Prior to the Offering, the KKR Stockholder owned 14,250,000 shares of KREF common stock, representing approximately 21.0% of KREFs outstanding shares of common stock as of June 1, 2022.
  • KREF will not receive any of the proceeds from the sale of the shares of KREF common stock by the KKR Stockholder.
  • KKR Real Estate Finance Trust Inc. (NYSE:KREF) is a real estate finance company that focuses primarily on originating and acquiring senior loans secured by commercial real estate properties.